Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Chronic liver disease (CLD) is responsible for significant morbidity and mortality. Most liver-related outcomes occur in people with advanced CLD, yet liver disease can be asymptomatic until the late ...

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...

The study builds on recent USC research showing that, for adolescents undergoing bariatric surgery to manage obesity, a PFAS ...

Familial hypobetalipoproteinemia (FHBL), caused by apolipoprotein B (APOB) variants, disrupts APOB-containing lipoprotein ...

New European and Latin American guidelines on the use of noninvasive tests for liver evaluation are the first to specifically address an approach that has become the standard in much of the developed ...

A research team from the Department of Medicine III at MedUni Vienna and University Hospital Vienna has conducted a large-scale study showing the important value of repeated liver assessments by a ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...

A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your doctor speaks an entirely different language. Two such acronyms you may be less ...

On Thursday, the Food and Drug Administration announced its approval of the first ever therapeutic treatment targeting metabolic dysfunction-associated steatohepatitis (MASH). This represents a ...

Through these partnerships the company will provide advanced diagnostic testing services to patients with Metabolic Dysfunction–associated Steatohepatitis (MASH), supporting more precise disease ...